Home Search

healthcare data - search results

If you're not happy with the results, please do another search
merck covid pill, molnupiravir

Merck says “COVID pill” can decrease risk of death by 50%

Pharmaceutical company, Merck, have a "COVID pill" at Phase 3 clinical trial - which seems to decrease risk of death by 50%.
one woman killed three days, sexual harassment, femicide

Research reveals one woman killed every three days in UK

A report by Femicide Census, an organisation that documents women killed by men, found that one woman is killed every three days in the UK - now, the rate of murder shows "no signs of reducing".
depression pandemic, COVID

Research finds people with depression “hidden group” vulnerable to pandemic

In a study of nearly 60,000 people by University College London, scientists found people with depression and anxiety before COVID were a "hidden group" - extra vulnerable to long-term health and financial consequences.
malnutrition, pregnancy

The burden of malnutrition

Christine Hancock, Co-founder of C3 Collaborating for Health, and C3 Associate and nutritionist Nathalie Vauterin, explore how poverty, dietary behaviours, and food systems impact malnutrition.
communication and information systems, computing

Computing, communication & information systems

Nina Amla with Joydip Kundu and Fernanda Pembleton from the Directorate for Computer and Information Science and Engineering (CISE), provide an in-depth look at computing, communication and information systems.
digital transformation NHS, vital hub UK

Digital transformation in the NHS

The digitalisation of healthcare is upon us, and Mike Sanders, Chief Executive Officer at Vital Hub UK Group of Companies advises on the best ways of providing effective digital care.
clinical backlog

Tackling the clinical backlog consequences of COVID-19

Keith Davies and Prof Dr Harald Braun of i5 Health & Analytics explain tackling the clinical backlog consequences of COVID-19.
safeguard the public sector

How to safeguard the public sector from growing cybercrime

Terry Greer-King, VP EMEA at Sonicwall, offers advice on how can the public sector protect itself from 2021's cybercrime 'explosion'.
menstrual cycle COVID vaccine,menstruation covid

NIH funds menstrual cycle and COVID vaccine research

McLean Hospital’s Clinical and Translational Pain Research Laboratory is one of five institutions splitting a $1.67 million NIH grant - the research will examine any links between the menstrual cycle and the COVID vaccine.

Clinical diagnostics revolution set to boost patient outcomes

Here, we learn how international diagnostics group Novacyt are leading the innovation revolution in clinical diagnostics through discovery, design, and innovation.
staff engagement solution, NHS staff experience

Enhancing NHS staff experience and the quality of patient care

Digital engagement solution, ImproveWell makes it simple for organisations to capture continuous, real-time and actionable insight from the frontline to improve staff experience and the quality of patient care - and it all began on the ward…
infection control

Infection prevention and control – Lessons learned

Andrew Metcalfe, Director of Intelligent Infection Control Services Limited, LumiBio, explores the lessons learned in infection prevention and control.
mental wellness

Empowering mental wellness through lived experience

Phil Worms, CEO of Frog Systems, explains how video-led signposting offers a new way to deliver well-being support.
national coding week

National Coding Week 2021 – Tech experts tackle the main issues  

Eight experts working across technology companies in software development, AI, public sector IT, data analytics and cybersecurity give their thoughts on the challenges and opportunities around National Coding Week.
the covid-19 vaccines

COVID-19 vaccines: Risks versus benefits

Lauren Matelski, Jeremy MacMahon, and Pamela J. Lein from the University of California, Davis, weigh the risks associated with COVID-19 vaccines versus the benefits.
third COVID dose, booster dose

UK approves Pfizer and AstraZeneca for third COVID dose

The UK medicine regulator approved both Pfizer and AstraZeneca vaccines as a third COVID dose - for use in a new UK booster scheme.
control of infections

Optimising infection control post-pandemic

Luke S. P. Moore, Infectious Diseases Physician and Clinical Microbiologist on behalf of the Healthcare Infection Society, directs our thoughts to optimising our control of infections and looks forward to the post-pandemic period.
performance analysis

Using performance analysis to help older people stay healthier for longer

Paul Berney, CMO at connected care platform Anthropos, explores how performance analysis, used to keep athletes healthy, can also be used to help older people stay healthier for longer.
regenerative medicine, regenerative

Japan: A case study of national “readiness” for regenerative medicine

This article focuses on Japan, as a country with a strong and distinctive strategy for delivering RM, and outlines efforts to build regenerative readiness.

Study reveals transgender people still face increased risk of death

In a study spanning fifty years, researchers reveal that transgender people still face a disproportionate likelihood of death - a likelihood not connected to gender-affirming hormone treatment.

Follow Us

Advertisements